Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003424070 | SCV004116644 | uncertain significance | DYNC2H1-related disorder | 2022-12-13 | criteria provided, single submitter | clinical testing | The DYNC2H1 c.1847_1852del6 variant is predicted to result in an in-frame deletion (p.Ile616_Leu617del). This variant was reported in the compound heterozygous state with another DYNC2H1 missense variant in a patient with perinatal lethal short-rib polydactyly syndrome (Zhang et al 2018. PubMed ID: 29068549). At PreventionGenetics, we have observed this variant with a rare missense variant in a similarly affected family member (internal data). This variant is reported in 0.0019% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-102996010-ATTATTC-A). Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Fulgent Genetics, |
RCV001291175 | SCV005678273 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | 2024-03-15 | criteria provided, single submitter | clinical testing | |
Dan Cohn Lab, |
RCV001291175 | SCV000611988 | pathogenic | Asphyxiating thoracic dystrophy 3 | 2017-06-01 | no assertion criteria provided | research | |
University of Washington Center for Mendelian Genomics, |
RCV001291175 | SCV001479578 | likely pathogenic | Asphyxiating thoracic dystrophy 3 | no assertion criteria provided | research |